Philip Nickson
Consigliere Generale presso MONTE ROSA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2024
Profilo
Philip Nickson is currently the Chief Business & Legal Officer at Monte Rosa Therapeutics, Inc. He previously worked as the Vice President-Intellectual Property at Momenta Pharmaceuticals, Inc. from 2012 to 2021.
Dr. Nickson holds a doctorate degree from The University of Manchester and a graduate degree from Suffolk University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Posizioni attive di Philip Nickson
| Società | Posizione | Inizio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Consigliere Generale | 01/03/2021 |
Precedenti posizioni note di Philip Nickson
| Società | Posizione | Fine |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2021 |
Formazione di Philip Nickson
| Suffolk University | Graduate Degree |
| The University of Manchester | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Philip Nickson
